Benzinga Rankings give you vital metrics on any stock – anytime.
Explore First Trust Amex Biotech Index Fund stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for FBT.
Open | $173.04 |
High | $175.37 |
52 Wk High | $183.60 |
AUM | 1.16B |
Dividend | - |
Ex-Div Date | - |
Volume | 16.11K |
Market Cap | $37.73B |
Mgmt Fee | 0.4% |
P/E Ratio | 25.78 |
Prev. Close | $173.47 |
Low | $172.13 |
52 Wk Low | $140.36 |
Shares Out | 7.55M |
Yield | - |
Div. Freq | - |
Avg. Volume Daily | 24.51K |
Beta | 0.67 |
Avg. Expense Ratio | 0.56% |
P/B Ratio | 4.27 |
You can purchase shares of First Trust Amex Biotech Index Fund (ARCA:FBT) through any online brokerage.
There are no as such competitors for First Trust Amex Biotech Index Fund.
There is no analysis for First Trust Amex Biotech Index Fund to provide a consensus price target.
The stock price for First Trust Amex Biotech Index Fund (ARCA: FBT) is $165.291 last updated December 30, 2024 at 4:01 PM EST.
A quarterly cash dividend of 0.06 per share of Class A Common Stock. The quarterly cash dividend was payable on June 30, 2015 to stockholders of record on June 24, 2015.
First Trust Amex Biotech Index Fund does not have any upcoming earnings scheduled.
There is no upcoming split for First Trust Amex Biotech Index Fund.
Open | $173.04 |
High | $175.37 |
52 Wk High | $183.60 |
AUM | 1.16B |
Dividend | - |
Ex-Div Date | - |
Volume | 16.11K |
Market Cap | $37.73B |
Mgmt Fee | 0.4% |
P/E Ratio | 25.78 |
Prev. Close | $173.47 |
Low | $172.13 |
52 Wk Low | $140.36 |
Shares Out | 7.55M |
Yield | - |
Div. Freq | - |
Avg. Volume Daily | 24.51K |
Beta | 0.67 |
Avg. Expense Ratio | 0.56% |
P/B Ratio | 4.27 |
Sector | Healthcare |
Category | High Performer-Mid Growth |
Investment Style | Mid Cap Growth |
Fund Inception | Jun 19, 2006 |
Managers | Stan Ueland Jon C. Erickson Chris A. Peterson Erik Russo Roger F. Testin Daniel J. Lindquist David G. McGarel |
Definition | This Equity Fund Portfolio contains majority of stocks with strong financial performance and average growth potential |
Symbol | Name | Share % |
---|---|---|
RGEN | Repligen Corp | 4.27% |
EXAS | Excat Scienece Corpora... | 3.99% |
ALKS | Alkermes Plc | 3.91% |
CORT | Corcept Therapeutics I... | 3.63% |
BGNE | Beigene, Ltd. Adr | 3.61% |
WAT | Waters Corp. | 3.60% |
GILD | Gilead Sciences Inc | 3.54% |
EXEL | Exelixis | 3.48% |
AS | Argenx Se Spon Adr Eac... | 3.44% |
ACAD | Acadia Pharmaceuticals... | 3.43% |